Evidence map›Paper›PMID 30577489›Full record

ArticleMolecules (Basel, Switzerland)2018

Lignans from

Mayra Antúnez-Mojica, Andrés M Rojas-Sepúlveda, Mario A Mendieta-Serrano, Leticia Gonzalez-Maya, Silvia Marquina, Enrique Salas-Vidal, Laura Alvarez

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Extracts fromFrontiers in pharmacology · 2026
    Article
  2. Phytochemical Profiles and Cytotoxic Activity ofPlants (Basel, Switzerland) · 2024
    Article
  3. Review
  4. Lignans fromLife (Basel, Switzerland) · 2021
    Review
  5. Lignans.Molecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mayra Antúnez-MojicaCONACYT-Centro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Morelos, Mexico. myam@uaem.mx.ORCID 0000-0002-1075-5947
Andrés M Rojas-SepúlvedaFacultad de Ciencias, Universidad Antonio Nariño, Armenia Quindío 63003, Colombia. andres.rojas@uan.edu.co.
Mario A Mendieta-SerranoDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Morelos, Mexico. mbimams@nus.edu.sg.ORCID 0000-0001-8620-5688
Leticia Gonzalez-MayaFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Morelos, Mexico. letymaya@uaem.mx.ORCID 0000-0002-4456-1235
Silvia MarquinaCentro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Morelos, Mexico. smarquina@uaem.mx.
Enrique Salas-VidalDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Morelos, Mexico. esalas@ibt.unam.mx.
Laura AlvarezCentro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Morelos, Mexico. lalvarez@uaem.mx.ORCID 0000-0001-7464-9898

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By using a zebrafish embryo model to guide the chromatographic fractionation of antimitotic secondary metabolites, seven podophyllotoxin-type lignans were isolated from a hydroalcoholic extract obtained from the steam bark of

Indexed as

AnimalsBurseraCell CycleCell MovementCytoskeletonLignansMicrotubulesMolecular StructureTubulinZebrafishLignansTubulinBursera fagaroidescancercell cyclecell migrationepibolyF-actinlignansmicrotubulespodophyllotoxin-type lignans

Identifiers

PMID30577489
PMCPMC6337621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.